3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
46
Kidney Neoplasms
11
Carcinoma, Renal Cell
11
Urinary Bladder Neoplasms
9
Neoplastic Cells, Circulating
8
Neoplasms
8
Breast Neoplasms
7
Neoplasm Metastasis
5
Melanoma
5
Sarcoma
4
Carcinoma, Non-Small-Cell Lung
4
Testicular Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Disease
3
Colorectal Neoplasms
3
von Hippel-Lindau Disease
2
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Prostatic Hyperplasia
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Liver Neoplasms
2
Leukemia
2
Kidney Diseases
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Clear-cell metastatic renal cell carcinoma
2
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
testosterone undecanoate
1
tempol
1
TEMPOL-H
1
Sirolimus
1
Nelfinavir
1
Metformin
1
Hydroxychloroquine
1
Gonadotropins
1
Diet, Protein-Restricted
1
Dasatinib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostate Cancer Recurrent
×
Blood Specimen Collection
×
Genitourinary
×
Clear all
NCT04324983
2023-04-12
BioPoP
Martini-Klinik am UKE GmbH
Phase NA
Completed
150 enrolled